Pictet Asset Management Holding Sa Alnylam Pharmaceuticals, Inc. Transaction History
Pictet Asset Management Holding Sa
- $90.1 Billion
- Q1 2024
A detailed history of Pictet Asset Management Holding Sa transactions in Alnylam Pharmaceuticals, Inc. stock. As of the latest transaction made, Pictet Asset Management Holding Sa holds 961,504 shares of ALNY stock, worth $234 Million. This represents 0.16% of its overall portfolio holdings.
Number of Shares
961,504
Previous 885,585
8.57%
Holding current value
$234 Million
Previous $170 Million
15.23%
% of portfolio
0.16%
Previous 0.19%
Shares
3 transactions
Others Institutions Holding ALNY
# of Institutions
584Shares Held
104MCall Options Held
2.82MPut Options Held
1.75M-
Capital World Investors Los Angeles, CA12.8MShares$3.11 Billion0.33% of portfolio
-
Vanguard Group Inc Valley Forge, PA12MShares$2.91 Billion0.04% of portfolio
-
Black Rock Inc. New York, NY9.03MShares$2.19 Billion0.03% of portfolio
-
Wellington Management Group LLP Boston, MA7.21MShares$1.75 Billion0.2% of portfolio
-
Baillie Gifford & CO6.62MShares$1.61 Billion0.78% of portfolio
About ALNYLAM PHARMACEUTICALS, INC.
- Ticker ALNY
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 123,028,000
- Market Cap $29.9B
- Description
- Alnylam Pharmaceuticals, Inc., a biopharmaceutical company, focuses on discovering, developing, and commercializing novel therapeutics based on ribonucleic acid interference. The company's pipeline of investigational RNAi therapeutics focuses on genetic medicines, cardio-metabolic diseases, hepatic infectious diseases, and central nervous system...